Pain Management Market Analysis | 2022-2028

Pain Management Market Analysis | 2022-2028

Pain Management Market Analysis | 2022-2028
Report code - SR1417 Delivery - 2 Weeks
Pain Management Market Growth, SIze, Share, Trends, Dynamics & Market Insights: 2022-2 See more...

Market Insights

"The pain management market was valued at US$ 68.4 billion in 2021 and is projected to reach US$ 94.86 billion by 2028, registering a CAGR of 4.76% during the forecast period."

Would you like to get a free sample? Register Here

What is pain management?

Pain is referred to as an unpleasant sensation in the body, due to ongoing or impending tissue damage. Pain management includes therapies, drugs, and devices that help alleviate the pain. Pain management products are employed to ease the suffering of the individual and improve the quality of life of those having chronic pain.

Pain Management Market Report Overview

Market Size in 2028

USD 94.86 billion

Market Size in 2021

USD 68.4 billion

CAGR (2022-2028)

4.76%

Base Year of Study

2021

Trend Period

2017-2020

Forecast Period

2022-2028

Key Players

Key players operating in the pain management market are:

Market Dynamics

The growth of the pain management market is primarily driven by increasing incidences of chronic illness including diabetic neuropathy, cancer, and osteoarthritis among others. Expanding the geriatric populace across geographies is another key factor that is likely to propel market growth during the review period. The rising number of surgical procedures due to increased accidental injuries is propelling market growth substantially. In addition to this, increasing investment in research and development activities to develop novel drugs is likely to create lucrative opportunities for the players operating in the global market in the coming years.

COVID-19 Impact

The COVID-19 outbreak impacted the growth of the pain management market positively as the demand for chronic pain management increased despite the pandemic. The spread of coronavirus led to the enforcement of lockdowns to curb the spread of the virus. This led to travel restrictions and supply chain disruptions, which affected the product supply for a short period.

Would you like to get a free sample? Register Here

Segment Analysis

Application Trends

"The cancer pain segment accounted for the largest market share."

The pain management market has been categorized into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others. The cancer pain segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. Pain during cancer primarily occurs when a tumor presses on the bones, nerves, or organs. The pain may vary according to the affected location. Pain caused by cancer can be treated. Many medicines are used for pain management in cancer patients.

Regional Insights

"North America accounted for the largest market share."

The market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to the expanding geriatric populace and the presence of key market players such as Pfizer, Johnson & Johnson, and Company (US) and Abbott Laboratories (US). The market in Asia-Pacific is expected to be driven by rising incidences of chronic wounds coupled with increased spending on healthcare.

Would you like to get a free sample? Register Here

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.

What deliverables will you get in this report?

Key questions this report answers

Relevant contents in the report

How big is the sales opportunity?

In-depth analysis of the Pain Management Market

How lucrative is the future?

Market forecast and trend data and emerging trends

Which regions offer the best sales opportunities?

Global, regional and country level historical data and forecasts

Which are the most attractive market segments?

Market segment analysis and forecast

Which are the top players and their market positioning?

Competitive landscape analysis, Market share analysis

How complex is the business environment?

Porter’s five forces analysis, PEST analysis, Life cycle analysis

What are the factors affecting the market?

Drivers & challenges

Will I get the information on my specific requirement?

10% free customization

 

Target Audience

Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert:

  • Distributors
  • Suppliers
  • Manufacturers
  • Logistics organizations
  • Government bodies

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The market is segmented into the following categories:

By Drugs Type

  • Drugs
  • Opioids [Non-narcotic Analgesics, NSAIDS, Anesthetics, Anticonvulsants, Anti-depressants]
  • Others

By Devices Type

  • Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Brain and Spinal Cord Stimulation (SCS) Devices]
  • Analgesic Infusion Pumps [Intrathecal Infusion Pumps, External Infusion Pumps]

By Application Type

  • Neuropathic Pain
  • Cancer Pain, Facial Pain, and Migraine
  • Musculoskeletal Pain
  • Others

By Region

  • North America
  • Asia-Pacific
  • Europe 
  • Rest of the World

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Pain is referred to as an unpleasant sensation in the body, due to ongoing or impending tissue damage. Pain management includes therapies, drugs, and devices that help alleviate the pain. Pain management products are employed to ease the suffering of the individual and improve the quality of life of those having chronic pain.

The pain management market was estimated to grow from USD 68.4 billion in 2021 to USD 94.86 billion by 2028.

The pain management market is expected to witness an impressive growth of 4.76% CAGR in the coming years.

Abbott Laboratories (US), Baxter International Inc. (US), Becton, Dickinson, Company (US), Boston Scientific Corporation (US), Fresenius SE & Co. KGaA (Germany), GlaxoSmithKline PLC (UK), Johnson & Johnson (US), Medtronic PLC (US), Novartis International AG (Switzerland), Pfizer Inc. (US).

North America accounted for the largest market share in 2021.

The growth of the pain management market is primarily driven by increasing incidences of chronic illness including diabetic neuropathy, cancer, and osteoarthritis among others. Expanding the geriatric populace across geographies is another key factor that is likely to propel market growth during the review period. The rising number of surgical procedures due to increased accidental injuries is propelling the market growth substantially. In addition to this, increasing investment in research and development activities to develop novel drugs is likely to create lucrative opportunities for the players operating in the global market in the coming years.

The cancer pain segment accounted for the largest market share in 2021.

By Drugs (Drugs, Opioids [Non-narcotic Analgesics, NSAIDS, Anesthetics, Anticonvulsants, Anti-depressants, Others), By Devices (Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Brain and Spinal Cord Stimulation (SCS) Devices], Analgesic Infusion Pumps [Intrathecal Infusion Pumps, External Infusion Pumps]), By Application (Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain, Others) and Region - COVID-19 Impact Analysis and Forecast to 2028.